Zoledronic Acid in Osteoporotic Vertebral Compression Fractures Treated with Percutaneous Kyphoplasty: A Meta-Analysis

Peng Tian,Yue Liu,Zhi-jun Li,Gui-jun Xu,Xin-long Ma
DOI: https://doi.org/10.3389/fsurg.2021.668551
IF: 1.8
2021-01-01
Frontiers in Surgery
Abstract:Background: We performed a meta-analysis to evaluate the efficacy and safety of zoledronic acid combined with percutaneous kyphoplasty (PKP) in treating osteoporotic vertebral compression fractures (OVCFs). Methods: Eligible scientific articles published prior to July 2020 were retrieved from the PubMed, Springer, ScienceDirect, and Cochrane Library databases. The statistical analysis was performed with RevMan 5.1. Results: Three randomized controlled trials (RCTs) and 2 non-RCTs met the inclusion criteria. The present meta-analysis revealed that zoledronic acid combined with PKP is associated with a higher BMD, a better quality of life, less severe low back pain, and fewer additional vertebral body fractures than is percutaneous vertebral augmentation alone. Conclusions: Compared with PKP only, zoledronic acid combined with percutaneous vertebral augmentation is beneficial for OVCFs.
What problem does this paper attempt to address?